on CROSSJECT (EPA:ALCJ)
Crossject to Participate in HC Wainwright’s 26th Annual Global Investment Conference
Crossject, a pharmaceutical company specializing in emergency medicines, will be attending HC Wainwright’s 26th Annual Global Investment Conference. The event will be held September 9-11, 2024 in New York City. Crossject will participate virtually and hold one-on-one meetings with investors.
The company will present its ZENEO® needle-free auto-injector. The presentation will be available on demand from September 9 via the conference platform. A replay will be available for 90 days on the Crossject website.
Investors can schedule an appointment with management via info@crossject.com. This participation aims to strengthen connections and informed discussions around investment prospects.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all CROSSJECT news